Citations (50)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Rosita A. Condorelli, Rossella Cannarella, Andrea Crafa, Federica Barbagallo, Carmelo Gusmano, Ottavia Avola, Laura M Mongioì, Livia Basile, Aldo E. Calogero & Sandro La Vignera. (2022) Advances in non-hormonal pharmacotherapy for the treatment of male infertility: the role of inositols. Expert Opinion on Pharmacotherapy 23:9, pages 1081-1090.
Read now
Read now
Mariano Bizzarri, Patrizia Logoteta, Giovanni Monastra & Antonio Simone Laganà. (2022) An innovative approach to polycystic ovary syndrome. Journal of Obstetrics and Gynaecology 42:4, pages 546-556.
Read now
Read now
Antonio Simone Laganà, Gianpiero Forte, Mariano Bizzarri, Zdravko A. Kamenov, Bianca Bianco, Cihan Kaya, Georgios Gitas, Ibrahim Alkatout, Milan Terzic & Vittorio Unfer. (2022) Inositols in the ovaries: activities and potential therapeutic applications. Expert Opinion on Drug Metabolism & Toxicology 18:2, pages 123-133.
Read now
Read now
Priyanka Prabhakar, Reeta Mahey, Monica Gupta, Rajesh Khadgawat, Garima Kachhawa, Jai Bhagwan Sharma, Perumal Vanamail, Rajesh Kumari & Neerja Bhatla. (2021) Impact of myoinositol with metformin and myoinositol alone in infertile PCOS women undergoing ovulation induction cycles - randomized controlled trial. Gynecological Endocrinology 37:4, pages 332-336.
Read now
Read now
Fabio Facchinetti, Pietro Cavalli, Andrew J. Copp, Rosario D’Anna, Eleni Kandaraki, Nicholas D. E. Greene & Vittorio Unfer. (2020) An update on the use of inositols in preventing gestational diabetes mellitus (GDM) and neural tube defects (NTDs). Expert Opinion on Drug Metabolism & Toxicology 16:12, pages 1187-1198.
Read now
Read now
Antonio Simone Laganà, Simone Garzon & Vittorio Unfer. (2020) New clinical targets of d-chiro-inositol: rationale and potential applications. Expert Opinion on Drug Metabolism & Toxicology 16:8, pages 703-710.
Read now
Read now
Luigi Della Corte, Virginia Foreste, Fabio Barra, Claudio Gustavino, Franco Alessandri, Maria Grazia Centurioni, Simone Ferrero, Giuseppe Bifulco & Pierluigi Giampaolino. (2020) Current and experimental drug therapy for the treatment of polycystic ovarian syndrome. Expert Opinion on Investigational Drugs 29:8, pages 819-830.
Read now
Read now
Fabio Facchinetti, Marialuisa Appetecchia, Cesare Aragona, Arturo Bevilacqua, Maria Salome Bezerra Espinola, Mariano Bizzarri, Rosario D’Anna, Didier Dewailly, Evanthia Diamanti-Kandarakis, Imelda Hernández Marín, Zdravko A. Kamenov, Eleni Kandaraki, Antonio Simone Laganà, Giovanni Monastra, Mario Montanino Oliva, John E. Nestler, Francesco Orio, Ali Cenk Ozay, Olga Papalou, Lali Pkhaladze, Giusy Porcaro, Nikos Prapas, Christophe O. Soulage, Annarita Stringaro, Artur Wdowiak & Vittorio Unfer. (2020) Experts’ opinion on inositols in treating polycystic ovary syndrome and non-insulin dependent diabetes mellitus: a further help for human reproduction and beyond. Expert Opinion on Drug Metabolism & Toxicology 16:3, pages 255-274.
Read now
Read now
Simone Garzon, Antonio Simone Laganà & Giovanni Monastra. (2019) Risk of reduced intestinal absorption of myo-inositol caused by D-chiro-inositol or by glucose transporter inhibitors. Expert Opinion on Drug Metabolism & Toxicology 15:9, pages 697-703.
Read now
Read now
Antoaneta Gateva, Vittorio Unfer & Zdravko Kamenov. (2018) The use of inositol(s) isomers in the management of polycystic ovary syndrome: a comprehensive review. Gynecological Endocrinology 34:7, pages 545-550.
Read now
Read now
Articles from other publishers (40)
Gaurika Aggarwal, Shikha Gupta, Ojus Sardana, Harleen, Pratima Kumari, Rupinder Kaur, Thakur Gurjeet Singh, Amit Sharma & Ravinder Singh. (2023) Comparison of efficacy of metformin and D-chiro-inositol on clinical biomarkers in patients with polycystic ovarian syndrome: an open label study. Global Health Journal.
Crossref
Crossref
Paul Ramp, Christina Mack, Astrid Wirtz & Michael Bott. (2023) Alternative routes for production of the drug candidate d-chiro-inositol with Corynebacterium glutamicum using endogenous or promiscuous plant enzymes. Metabolic Engineering 78, pages 1-10.
Crossref
Crossref
Vittorio Unfer, Simona Dinicola & Michele Russo. (2023) A PCOS Paradox: Does Inositol Therapy Find a Rationale in All the Different Phenotypes?. International Journal of Molecular Sciences 24:7, pages 6213.
Crossref
Crossref
Maria Salomé Bezerra Espinola, Artur Wdowiak & Tony Chiu Tak Yu. 2023. A Clinical Guide to Inositols. A Clinical Guide to Inositols
167
174
.
Tonino Cantelmi & Cherubino Di Lorenzo. 2023. A Clinical Guide to Inositols. A Clinical Guide to Inositols
73
85
.
Xuan Ji, Luke Webster, Taylor J. Wass & Peer M. Schenk. 2022. Algal Functional Foods and Nutraceuticals: Benefits, Opportunities, and Challenges. Algal Functional Foods and Nutraceuticals: Benefits, Opportunities, and Challenges
29
44
.
Kamyar Zahedi, Sharon Barone, Marybeth Brooks, Tracy Murray Stewart, Robert A. CaseroJr.Jr. & Manoocher Soleimani. (2022) Renal Transcriptome and Metabolome in Mice with Principal Cell-Specific Ablation of the Tsc1 Gene: Derangements in Pathways Associated with Cell Metabolism, Growth and Acid Secretion. International Journal of Molecular Sciences 23:18, pages 10601.
Crossref
Crossref
Vincenzo Cardinale, Elisa Lepore, Sabrina Basciani, Salvatore Artale, Maurizio Nordio, Mariano Bizzarri & Vittorio Unfer. (2022) Positive Effects of α-Lactalbumin in the Management of Symptoms of Polycystic Ovary Syndrome. Nutrients 14:15, pages 3220.
Crossref
Crossref
Garima Kachhawa, Krithika V. Senthil Kumar, Vidushi Kulshrestha, Rajesh Khadgawat, Reeta Mahey & Neerja Bhatla. (2021)
Efficacy of myo‐inositol and
d
‐chiro‐inositol combination on menstrual cycle regulation and improving insulin resistance in young women with polycystic ovary syndrome: A randomized open‐label study
. International Journal of Gynecology & Obstetrics 158:2, pages 278-284.
Crossref
Crossref
Qiaoli Zhang, Rongcai Ye, Yuan-Yuan Zhang, Chen-Chen Fan, Jun Wang, Shuyu Wang, Suwen Chen & Xiaowei Liu. (2022) Brown Adipose Tissue and Novel Management Strategies for Polycystic Ovary Syndrome Therapy. Frontiers in Endocrinology 13.
Crossref
Crossref
Weixuan Chen & Yanli Pang. (2021) Metabolic Syndrome and PCOS: Pathogenesis and the Role of Metabolites. Metabolites 11:12, pages 869.
Crossref
Crossref
Abdel Halim Harrath, Maroua Jalouli, Mohamed Habib Oueslati, Mohammad Abul Farah, Anouar Feriani, Waleed Aldahmash, Nouf Aldawood, Khalid Al‐Anazi, Fawaz Falodah, Ayman Swelum & Saleh Alwasel. (2021)
The flavonoid,
kaempferol‐3‐O‐apiofuranosyl‐7‐O
‐rhamnopyranosyl, as a potential therapeutic agent for breast cancer with a promoting effect on ovarian function
. Phytotherapy Research 35:11, pages 6170-6180.
Crossref
Crossref
Simona Dinicola, Vittorio Unfer, Fabio Facchinetti, Christophe O. Soulage, Nicholas D. Greene, Mariano Bizzarri, Antonio Simone Laganà, Shiao-Yng Chan, Arturo Bevilacqua, Lali Pkhaladze, Salvatore Benvenga, Annarita Stringaro, Daniele Barbaro, Marialuisa Appetecchia, Cesare Aragona, Maria Salomè Bezerra Espinola, Tonino Cantelmi, Pietro Cavalli, Tony T. Chiu, Andrew J. Copp, Rosario D’Anna, Didier Dewailly, Cherubino Di Lorenzo, Evanthia Diamanti-Kandarakis, Imelda Hernández Marín, Moshe Hod, Zdravko Kamenov, Eleni Kandaraki, Giovanni Monastra, Mario Montanino Oliva, John E. Nestler, Maurizio Nordio, Ali C. Ozay, Olga Papalou, Giuseppina Porcaro, Nikos Prapas, Scott Roseff, Monica Vazquez-Levin, Ivana Vucenik & Artur Wdowiak. (2021) Inositols: From Established Knowledge to Novel Approaches. International Journal of Molecular Sciences 22:19, pages 10575.
Crossref
Crossref
Waleed Hassan Almalki. (2021) A review on inositol’s potential in cyclic disturbances of adipose-endocrinology-associated polycystic ovary syndrome. Molecular and Cellular Biochemistry 476:8, pages 2943-2949.
Crossref
Crossref
Selma FIRAT & Mehmet FİSUNOĞLU. (2021) Polikistik Over Sendromunda Güncel Terapötik Ajanlardan İnositol ve Alfa Lipoik Asit Takviyesi Üzerine Bir Derleme. Akdeniz Medical Journal 7:2, pages 184-196.
Crossref
Crossref
Siarhei A. Dabravolski, Nikita G. Nikiforov, Ali H. Eid, Ludmila V. Nedosugova, Antonina V. Starodubova, Tatyana V. Popkova, Evgeny E. Bezsonov & Alexander N. Orekhov. (2021) Mitochondrial Dysfunction and Chronic Inflammation in Polycystic Ovary Syndrome. International Journal of Molecular Sciences 22:8, pages 3923.
Crossref
Crossref
Fernando Gonzalez-Uarquin, Vera Sommerfeld, Markus Rodehutscord & Korinna Huber. (2021) Interrelationship of myo-inositol pathways with systemic metabolic conditions in two strains of high-performance laying hens during their productive life span. Scientific Reports 11:1.
Crossref
Crossref
Anita Cunha & Ana Margarida Póvoa. (2021) Infertility management in women with polycystic ovary syndrome: a review. Porto Biomedical Journal 6:1, pages e116.
Crossref
Crossref
Eser Colak, Emel Ebru Ozcimen, Yusuf Aytac Tohma & Mehmet Ufuk Ceran. (2020)
May myo‐inositol and
d
‐chiro‐inositol (40:1) treatment be a good option on normal‐weighted polycystic ovary syndrome patients without insulin resistance?
. Journal of Obstetrics and Gynaecology Research 46:12, pages 2605-2611.
Crossref
Crossref
Vittorio Unfer & Gianpiero Forte. (2020) Does inositol ratio orchestrate the fate of ovarian follicles?. Medical Hypotheses 144, pages 109983.
Crossref
Crossref
María Victoria De Diego, Olga Gómez-Pardo, Janette Kirk Groar, Alejandro López-Escobar, Irene Martín-Estal, Inma Castilla-Cortázar & Miguel Ángel Rodríguez-Zambrano. (2020) Metabolic impact of current therapeutic strategies in Polycystic Ovary Syndrome: a preliminary study. Archives of Gynecology and Obstetrics 302:5, pages 1169-1179.
Crossref
Crossref
Vittorio Unfer, Simona Dinicola, Antonio Simone Laganà & Mariano Bizzarri. (2020) Altered Ovarian Inositol Ratios May Account for Pathological Steroidogenesis in PCOS. International Journal of Molecular Sciences 21:19, pages 7157.
Crossref
Crossref
Agata Wawrzkiewicz-Jałowiecka, Karolina Kowalczyk, Paulina Trybek, Tomasz Jarosz, Patrycja Radosz, Marcin Setlak & Paweł Madej. (2020) In Search of New Therapeutics—Molecular Aspects of the PCOS Pathophysiology: Genetics, Hormones, Metabolism and Beyond. International Journal of Molecular Sciences 21:19, pages 7054.
Crossref
Crossref
Serena L’Abbate, Giuseppina Nicolini, Francesca Forini, Sabrina Marchetti, Nicole Di Lascio, Francesco Faita & Claudia Kusmic. (2020) Myo–inositol and d-chiro–inositol oral supplementation ameliorate cardiac dysfunction and remodeling in a mouse model of diet-induced obesity. Pharmacological Research 159, pages 105047.
Crossref
Crossref
Eva Pericuesta, Ricardo Laguna-Barraza, Priscila Ramos-Ibeas, Julia L. Gutierrez-Arroyo, Juan A. Navarro, Katia Vera, Carlos Sanjuan, Elena Baixeras, Fernando Rodríguez de Fonseca & Alfonso Gutierrez-Adan. (2020) D-Chiro-Inositol Treatment Affects Oocyte and Embryo Quality and Improves Glucose Intolerance in Both Aged Mice and Mouse Models of Polycystic Ovarian Syndrome. International Journal of Molecular Sciences 21:17, pages 6049.
Crossref
Crossref
Fabio Facchinetti, Maria Salome Bezerra Espinola, Didier Dewailly, Ali Cenk Ozay, Nikos Prapas, Mónica Vazquez-Levin, Artur Wdowiak, Vittorio Unfer, Fabio Facchinetti, Vittorio Unfer, Marialuisa Appetecchia, Cesare Aragona, Matteo Bertelli, Arturo Bevilacqua, Maria Salome Bezerra Espinola, Mariano Bizzarri, Pietro Cavalli, Andrew Copp, Rosario D’Anna, Didier Dewailly, Nicholas Greene, Imelda Hernández Marín, Zdravko A. Kamenov, Eleni Kandaraki, Evanthia Diamanti-Kandarakis, Antonio Simone Laganà, Giovanni Monastra, Mario Montanino Oliva, John E. Nestler, Ali Cenk Ozay, Olga Papalou, Lali Pkhaladze, Giusy Porcaro, Nikos Prapas, Christophe O. Soulage, Annarita Stringaro, Mónica Vazquez-Levin & Artur Wdowiak. (2020) Breakthroughs in the Use of Inositols for Assisted Reproductive Treatment (ART). Trends in Endocrinology & Metabolism 31:8, pages 570-579.
Crossref
Crossref
Thalia Tsiaka, Charalambos Fotakis, Dimitra Z. Lantzouraki, Konstantinos Tsiantas, Eleni Siapi, Vassilia J. Sinanoglou & Panagiotis Zoumpoulakis. (2020) Expanding the Role of Sub-Exploited DOE-High Energy Extraction and Metabolomic Profiling towards Agro-Byproduct Valorization: The Case of Carotenoid-Rich Apricot Pulp. Molecules 25:11, pages 2702.
Crossref
Crossref
Fabio Facchinetti, Vittorio Unfer, Didier Dewailly, Zdravko A. Kamenov, Evanthia Diamanti-Kandarakis, Antonio Simone Laganà, John E. Nestler & Christophe O. Soulage. (2020) Inositols in Polycystic Ovary Syndrome: An Overview on the Advances. Trends in Endocrinology & Metabolism 31:6, pages 435-447.
Crossref
Crossref
Т. Ф Татарчук, Н. В. Косей, Т. М. Тутченко & М. І. Гламазда. (2020) Optimization of ovarian function and metabolic status in syndrome of polycystic ovaries. REPRODUCTIVE ENDOCRINOLOGY:52, pages 18-22.
Crossref
Crossref
Rosita A. Condorelli, Federica Barbagallo, Aldo E. Calogero, Rossella Cannarella, Andrea Crafa & Sandro La Vignera. (2020) D-Chiro-Inositol Improves Sperm Mitochondrial Membrane Potential: In Vitro Evidence. Journal of Clinical Medicine 9:5, pages 1373.
Crossref
Crossref
Scott Roseff & Marta Montenegro. (2020) Inositol Treatment for PCOS Should Be Science-Based and Not Arbitrary. International Journal of Endocrinology 2020, pages 1-8.
Crossref
Crossref
M.H. Vazquez-Levin & G.L. Verón. (2019) Myo‐inositol in health and disease: its impact on semen parameters and male fertility. Andrology 8:2, pages 277-298.
Crossref
Crossref
Ileana Andreea Ratiu, Hossam Al-Suod, Magdalena Ligor, Tomasz Ligor, Aneta Krakowska, Ryszard Górecki & Bogusław Buszewski. (2019) Simultaneous Determination of Cyclitols and Sugars Following a Comprehensive Investigation of 40 Plants. Food Analytical Methods 12:6, pages 1466-1478.
Crossref
Crossref
Arturo Bevilacqua, Jessica Dragotto, Alessandro Giuliani & Mariano Bizzarri. (2018) Myo‐inositol and D‐chiro‐inositol (40:1) reverse histological and functional features of polycystic ovary syndrome in a mouse model. Journal of Cellular Physiology 234:6, pages 9387-9398.
Crossref
Crossref
Ana L. Rocha, Flávia R. Oliveira, Rosana C. Azevedo, Virginia A. Silva, Thais M. Peres, Ana L. Candido, Karina B. Gomes & Fernando M. Reis. (2019) Recent advances in the understanding and management of polycystic ovary syndrome. F1000Research 8, pages 565.
Crossref
Crossref
Robert H. Michell. (2018) Do inositol supplements enhance phosphatidylinositol supply and thus support endoplasmic reticulum function?. British Journal of Nutrition 120:3, pages 301-316.
Crossref
Crossref
Costanzo Moretti & Giulia Lanzolla. (2018) Uso dell’inositolo nella sindrome dell’ovaio policistico. L'Endocrinologo 19:S1, pages 17-19.
Crossref
Crossref
Kendall C. Case, Michael Salsaa, Wenxi Yu & Miriam L. Greenberg. 2020. Lipid Signaling in Human Diseases. Lipid Signaling in Human Diseases
221
260
.
R Hanna, T Wehbe & EA Jaoude. (2017) Metabolic Effects of D-Chiro-Inositol and Myo-Inositol in Polycystic Ovary Syndrome. International Journal of Clinical Endocrinology and Metabolism 3:1, pages 029-033.
Crossref
Crossref
Nicolás Mendoza, Laura Pérez, Tommaso Simoncini & Alessandro Genazzani. (2017) Inositol supplementation in women with polycystic ovary syndrome undergoing intracytoplasmic sperm injection: a systematic review and meta-analysis of randomized controlled trials. Reproductive BioMedicine Online 35:5, pages 529-535.
Crossref
Crossref